aan welke wetenschappelijke publicaties hebben medewerkers van het cbg in 2009 (mee) gewerkt?
Hieronder staat een overzicht van wetenschappelijke publicaties
waaraan CBG-medewerkers hebben (mee)gewerkt in 2009. Deze
publicaties hoeven niet noodzakelijkerwijs de mening van het
CBG te reflecteren.
Calcium channel blockers, NOS1AP, and heart-rate-corrected QT
prolongation
Van Noord C, Aarnoudse AJ, Eijgelsheim M, Sturkenboom MC, Straus
SM, Hofman A, Kors JA, Newton-Cheh C, Witteman JC, Stricker BH.
Pharmacogenet Genomics. 2009 Apr;19(4):260-6.
Evaluation of Post-Authorization Safety Studies in the
First Cohort of EU Risk Management Plans at Time of Regulatory
Approval
Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.;
Straus, Sabine M.J.M.; Egberts, Toine C.G.; Blackburn, Stella;
Persson, Ingemar; Leufkens, Hubert G.M. Drug Safety.
32(12):1175-1187 | December 1, 2009.
Genetic variation in NOS1AP is associated with
sudden cardiac death: evidence from the Rotterdam Study
Eijgelsheim M, Newton-Cheh C, Aarnoudse AL, van Noord C, Witteman
JC, Hofman A, Uitterlinden AG, Stricker BH. Hum Mol Genet.
2009 Nov 1;18(21):4213-8. Epub 2009 Jul 30.
HTR2C
gene polymorphisms and the metabolic syndrome in patients with
schizophrenia: a replication study
Mulder H, Cohen D, Scheffer H, Gispen-de Wied C, Arends J, Wilmink
FW, Franke B, Egberts AC.
J Clin Psychopharmacol. 2009
Feb;29(1):16-20.
Large scale replication and meta-analysis of variants on chromosome
4q25 associated with atrial fibrillation
Kääb S, Darbar D, van Noord C, Dupuis J, Pfeufer A, Newton-Cheh C,
Schnabel R, Makino S, Sinner MF, Kannankeril PJ, Beckmann BM,
Choudry S, Donahue BS, Heeringa J, Perz S, Lunetta KL, Larson MG,
Levy D, MacRae CA, Ruskin JN, Wacker A, Schömig A, Wichmann HE,
Steinbeck G, Meitinger T, Uitterlinden AG, Witteman JC, Roden DM,
Benjamin EJ, Ellinor PT.
Eur Heart J. 2009 Apr;30(7):813-9. Epub 2009 Jan
13.
Phase I pharmacokinetic and pharmacodynamic study of Carboplatin
and topotecan administered intravenously every 28 days to patients
with malignant solid tumors
Boss DS, Siegel-Lakhai WS, van Egmond-Schoemaker NE, Pluim D,
Rosing H, Ten Bokkel Huinink WW, Beijnen JH, Schellens JH;
Clin Cancer Res. 2009 Jul 1 | 15(13):4475-83. Epub 2009 Jun
16.
Pharmacovigilance of Biopharmaceuticals. Challenges Remain
Giezen, T.J., Mantel-Teeuwisse, A.K. & Leufkens, H.G.M. (2009)
Drug Safety, 32(10), 811-817
Pharmacovigilance of biosimilars from a
regulatory point of view: Is there a need for a specific
approach?
T.J. Giezen, S.M.J.M. Straus, A.K. Mantel-Teeuwisse (2009)
International Journal of Risk and Safety in Medicine, 21(1-2),
53-58
Population-based studies of antithyroid drugs
and sudden cardiac death
Van Noord C, Sturkenboom MC, Straus SM, Hofman A, Witteman JC,
Stricker BH. Br J Clin Pharmacol. 2009
Sep;68(3):447-54.
Psychopharmacology for children: From off label
use to registration
Wohlfarth T, Kalverdijk L, Rademaker
C, Schothorst P, Minderaa R, Gispen-de Wied C (2009)
European Neuropsychopharmacology. 19, 603–608 |
doi:10.1016/j.euroneuro.2009.04.007
Psychotropic drugs associated with corrected QT interval
prolongation
Van Noord C, Straus SM, Sturkenboom MC, Hofman A, Aarnoudse AJ,
Bagnardi V, Kors JA, Newton-Cheh C, Witteman JC, Stricker BH.
J Clin Psychopharmacol. 2009 Feb;29(1):9-15.
Serum
glucose and insulin are associated with QTc and RR intervals in
nondiabetic elderly
Van Noord C, Sturkenboom MC, Straus SM,
Hofman A, Kors JA, Witteman JC, Stricker BH.
Eur J Endocrinol. 2010 Feb;162(2):241-8. Epub 2009 Nov
6.
The
association of serum testosterone levels and ventricular
repolarization
van Noord C, Dörr M, Sturkenboom MC, Straus SM, Reffelmann T, Felix
SB, Hofman A, Kors JA, Haring R, de Jong FH, Nauck M, Uitterlinden
AG, Wallaschofski H, Witteman JC, Völzke H, Stricker BH.
Eur J Epidemiol. 2010;25(1):21-8. Epub 2009 Dec
3.
The validity of biomarkers as surrogate endpoints in Alzheimer’s
disease by means of the Quantitative Surrogate Validation Level of
Evidence Scheme (QSVLES)
C. C. Gispen-De Wied, M. Kritsidima, A. J. A. Elferink
(2009) The Journal of Nutrition, Health and Aging, 2009
Apr;13(4):376-87
Requirements for generic anti-epileptic medicines: a
regulatory perspective
Marc Maliepaard; Yechiel A. Hekster; Arnoud Kappelle; Eugène P. van
Puijenbroek; Andre´ J. Elferink; Jan Welink; Christine C. Gispen-de
Wied; Frits J. F. Lekkerkerker J Neurol (2009)
256:1966–1971 | DOI 10.1007/s00415-009-5231-2
Variants in ZFHX3 are associated with atrial
fibrillation in individuals of European ancestry
Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV,
Schnabel RB, Bis JC, Boerwinkle E, Sinner MF, Dehghan A, Lubitz SA,
D'Agostino RB Sr, Lumley T, Ehret GB, Heeringa J, Aspelund T,
Newton-Cheh C, Larson MG, Marciante KD, Soliman EZ, Rivadeneira F,
Wang TJ, Eiríksdottir G, Levy D, Psaty BM, Li M, Chamberlain AM,
Hofman A, Vasan RS, Harris TB, Rotter JI, Kao WH, Agarwal SK,
Stricker BH, Wang K, Launer LJ, Smith NL, Chakravarti A,
Uitterlinden AG, Wolf PA, Sotoodehnia N, Köttgen A, van Duijn CM,
Meitinger T, Mueller M, Perz S, Steinbeck G, Wichmann HE, Lunetta
KL, Heckbert SR, Gudnason V, Alonso A, Kääb S, Ellinor PT, Witteman
JC. Nat Genet. 2009 Aug;41(8):879-81. Epub 2009 Jul
13.